Top

Familial Cancer

Published in:

01-12-2010

Hereditary predisposition rather than environmental factor are likely to explain the familial link between uveal melanoma and other cancers

Authors: M. H. Abdel-Rahman, R. Pilarski

Published in: Familial Cancer | Issue 4/2010

Excerpt

Sir, …

Grant WB, Moan JE, Micu E, Porojnicu AC, Juzeniene A (2010) Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers. Fam Cancer. doi:10.1007/s10689-010-9374-1

Abdel-Rahman MH, Pilarski R, Ezzat S, Sexton J, Davidorf FH (2010) Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma. Fam Cancer 9(3):431–438CrossRefPubMed

Moan J, Cicarma E, Setlow R, Porojnicu AC, Grant WB, Juzeniene A (2010) Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation. Dermatoendocrinol 2(1):3–8CrossRef

IARC (2008) Vitamin D and cancer. IARC Working Group Reports, vol 5. International Agency for Research on Cancer, Lyon, 25 Nov 2008

Helzlsouer KJ (2010) Overview of the cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172(1):4–9CrossRefPubMed

Singh AD, Rennie IG, Seregard S, Giblin M, McKenzie J (2004) Sunlight exposure, pathogenesis of uveal melanoma. Surv Ophthalmol 49(4):419–428CrossRefPubMed

Tucker MA (2009) Melanoma epidemiology. Hematol Oncol Clin North Am 23(3):383–395CrossRefPubMed

Nelson AA, Tsao H (2009) Melanoma and genetics. Clin Dermatol 27(1):46–52CrossRefPubMed

Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review, compilation of risk assessment criteria. J Med Genet 41(2):81–91CrossRefPubMed

Title: Hereditary predisposition rather than environmental factor are likely to explain the familial link between uveal melanoma and other cancers
Authors: M. H. Abdel-Rahman
R. Pilarski
Publication date: 01-12-2010
Publisher: Springer Netherlands
Published in: Familial Cancer / Issue 4/2010
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-010-9375-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2010

Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

Thymoma associated with malignancies may herald a hereditary cancer syndrome

Contribution of CDKN2A/P16 INK4A , P14 ARF , CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma

Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers

A novel mutation of the Succinate Dehydrogenase B Gene in a Korean Family with Pheochromocytoma

Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits

Keynote webinar | Spotlight on antibody–drug conjugates in cancer